Prothena Corp. Plc (PRTA)
8.26
-0.14
(-1.67%)
USD |
NASDAQ |
Nov 20, 12:16
Prothena Cash from Investing (Quarterly) : -0.0686M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0686M |
| June 30, 2026 | -0.6499M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.002M |
| September 30, 2025 | -0.0115M |
| June 30, 2025 | -0.0908M |
| March 31, 2025 | -0.042M |
| December 31, 2024 | -0.0361M |
| September 30, 2024 | -0.0126M |
| June 30, 2024 | -0.142M |
| March 31, 2024 | -0.103M |
| December 31, 2023 | -1.489M |
| September 30, 2023 | -0.4446M |
| June 30, 2023 | -0.7769M |
| March 31, 2023 | -0.048M |
| December 31, 2022 | -0.1554M |
| September 30, 2022 | -0.1166M |
| June 30, 2022 | -0.1563M |
| March 31, 2022 | -0.022M |
| December 31, 2021 | -0.3042M |
| September 30, 2021 | -0.2039M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.048M |
| December 31, 2020 | -0.054M |
| September 30, 2020 | -0.083M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.046M |
| March 31, 2020 | -0.022M |
| December 31, 2019 | -0.1051M |
| September 30, 2019 | -0.2449M |
| June 30, 2019 | -0.068M |
| March 31, 2019 | -0.123M |
| December 31, 2018 | -1.251M |
| September 30, 2018 | -0.1457M |
| June 30, 2018 | -0.0947M |
| March 31, 2018 | -0.181M |
| December 31, 2017 | -0.3363M |
| September 30, 2017 | -0.6884M |
| June 30, 2017 | -0.2515M |
| March 31, 2017 | -2.399M |
| December 31, 2016 | -2.625M |
| September 30, 2016 | -8.532M |
| June 30, 2016 | -4.819M |
| March 31, 2016 | -0.238M |
| December 31, 2015 | -0.9718M |
| September 30, 2015 | -0.3248M |
| June 30, 2015 | -0.0395M |
| March 31, 2015 | -0.028M |
| December 31, 2014 | -0.0215M |
| September 30, 2014 | -0.0952M |
| June 30, 2014 | -0.3271M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alkermes Plc | 19.99M |
| Amarin Corp. Plc | 4.556M |
| Agenus, Inc. | -19.88M |
| Amgen, Inc. | -649.00M |
| Anika Therapeutics, Inc. | -1.756M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.88M |
| Cash from Financing (Quarterly) | -4.615M |
| Free Cash Flow | -30.75M |
| Free Cash Flow Per Share (Quarterly) | -0.2322 |
| Free Cash Flow to Equity (Quarterly) | -11.21M |
| Free Cash Flow to Firm (Quarterly) | -11.95M |
| Free Cash Flow Yield | -7.25% |